AB

ABL Bio Venture Capital

South Korea, KR · 2 known investors

ablbio.com ↗

ABL Bio develops biotherapeutic drugs using dual antibody platform technology for immunotherapy cancer treatments and degenerative neurological diseases. The company is a South Korea-based biotech research firm with proprietary platforms designed to treat intractable diseases.

Investors · 2

AT

Atinum Investment Co. Ltd.Seoul · $100K – $2M

IM

IMM Investment JapanSeoul